Since natriuretic peptide and troponin are associated with renal prognosis and left atrial (LA) parameters are indicators of subclinical cardiovascular abnormalities, this study investigated whether LA expansion index can predict renal decline. 
Introduction
Renal dysfunction has large and well-recognized effects on cardiac structure and is a useful predictor of cardiovascular disease outcome. 1, 2 However, studies also suggest that renal function can be affected by treatment for heart failure (HF) or by HF itself. 3, 4 The heart and the kidney share similar risk factors and are apparently common endpoints of vascular problems. Moreover, a recent study of stable angina patients without clinical HF showed that baseline N-terminal pro-B-type natriuretic peptide (NT-ProBNP) predicted rapid and incidental declines in renal function 5 years later. 5 Another study of elderly adults without HF revealed that NT-ProBNP and troponin T are associated with rapid decline in kidney function and incidental chronic kidney disease. 6 Even in patients without HF, mild elevation of these parameters indicates subclinical cardiovascular abnormalities that can affect renal function. The detailed mechanisms of this association are still unclear, but some researchers have investigated the effects of factors such as arterial stiffness. 7, 8 A growing body of evidence suggests that other possible causes include the complex interaction between impaired mineral metabolism and vascular calcification, over-activation of the rennin-angiotensin-aldosterone system, endothelial dysfunction, and inflammatory processes.
As an indicator of subtle subclinical cardiovascular abnormalities, the left atrium (LA) is more suitable than the left ventricle (LV). For example, the LA is much thinner, which makes it a better early indicator of LV diastolic dysfunction. Therefore, we hypothesized that morphological changes in the LA are not only early indicators of cardiovascular disease but also predictors of decline in renal function. Additionally, LA expansion index is reportedly a useful indicator of subtle impairments in diastolic function before major geographic changes in LV occur and is a useful prognostic indicator in many disease entities. [9] [10] [11] [12] [13] [14] [15] Therefore, this study evaluated the use of LA expansion index for predicting degradation of renal function.
Methods

Study population
The study cohort was prospectively enrolled from the cardiovascular outpatient clinic of a tertiary medical centre and mostly referred for dyspnoea evaluation. Renal dysfunction was defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m 2 calculated using the modification of diet in renal disease (MDRD) formula with serum creatinine. Diabetes mellitus was defined according to American Diabetes Association criteria. 16 This study consecutively enrolled non-diabetic patients who had preserved LV systolic function and renal functions that were within normal limits. Other exclusion criteria were the following: (i) history of HF hospitalization, valvular heart disease of more than moderate severity, prosthetic valve implantation, myocardial infarction, acute coronary syndrome, or LV ejection fraction <50%; (ii) any atrial septal abnormality (e.g. defect or aneurysm); (iii) rhythm other than sinus rhythm; (iv) inadequate image quality; and (v) lack of informed consent. Histories of hyperlipidaemia, hypertension, and smoking were recorded by the examining physicians. High blood pressure was defined as elevated systolic (>140 mmHg) or diastolic (>90 mmHg) blood pressure observed by examining physicians in each of two measurements. Subjects were considered hypertensive if they had high blood pressure or were currently receiving hypertension drug treatment at the index examinations. Coronary artery disease was defined as any history of the following: (i) myocardial infarction, (ii) at least 70% stenosis in one or more coronary vessels on cardiac catheterization, (iii) exercise-induced ischaemia indicated by treadmill electrocardiogram (ECG) or nuclear perfusion stress imaging, or (iv) coronary revascularization.
Echocardiographic measurements
Echocardiography (iE33 system; Philips Medical System, Andover, MA, USA) was performed in left decubitus position for maximum image quality. Trans-mitral flow profiles, including peak early-diastolic flow velocity (E), late-diastolic flow velocity (A), and mitral early deceleration time, were assessed. The LV ejection fraction was calculated using Simpson's biplane technique. Pulmonary artery systolic pressure was estimated using Doppler echocardiography by calculating the right ventricular to right atrial pressure gradient during systole, approximated by the modified Bernoulli equation 4V 2 , where V is the velocity of the tricuspid regurgitation jet in m/s. Right atrial pressure estimated according to echocardiographic characteristics of the inferior vena cava was assigned a standardized value and added to the calculated gradient. 17 LV mass was calculated using the formula described by Devereux and Reichek. 18 LV mass was indexed to body surface area (BSA). Pulsed-wave tissue Doppler imaging (TDI) was performed using spectral pulsed Doppler signal filters with the Nyquist limit adjusted to 15-20 cm/s and with the optimal gain set to minimum. In apical view, a pulsed-wave Doppler sample volume was placed at the level of the mitral annulus over the septal and lateral borders. Pulsed-wave TDI results were characterized by a myocardial systolic wave (s 0 ) and two diastolic waves: early (e 0 ) and atrial contraction (a 0 ). Pulsed-wave TDI tracing recorded over five cardiac cycles at a sweep speed of 100 mm/s was used for offline calculations. The average e 0 of septal and lateral mitral annulus was used to estimate LV filling pressure by the E/e 0 method. 19 Preserved LV systolic function was defined as LV ejection fraction higher than 50%. Diastolic dysfunction was assessed as described previously. 20, 21 All LA volume measurements were calculated by biplane area-length method in apical four-and two-chamber views. 22 Renal function follow-up
Participants were followed up at outpatient clinic every 3 months. Patients received renal function checkups at least annually for 5 years. When using linear regression method to measure renal decline, eGFR was calculated using the four-variable MDRD formula with serum creatinine. In each participant, the rate of decline was based on at least 4-6 eGFR results (obtained during a period of 12-60 months) for an accurate calculation of the rate of change in eGFR over time. [23] [24] [25] In the follow-up analysis, rapid decline in kidney function and incidental decline in renal function were used as the kidney outcome. Rapid decline in kidney function was defined as an annual decline in GFR >3 mL/min/ 
Heart conditions follow-up
Participants were followed up every 3 months for at least 5 years and a resting ECG was obtained annually through the whole follow-up period. If participants complained with palpitations, 24-h Holter monitorings were performed to detect arrhythmia patterns. Participants having atrial fibrillation (AF) events, another visit would be scheduled the following week to confirm persistence of AF. The prescription of oral anticoagulant, rate control medications, or anti-arrhythmic drugs was dependent on the discretion of their personal physicians. HF was defined as a hospital stay of !1 night for treatment of a clinical syndrome with !2 of the following symptoms: paroxysmal nocturnal dyspnoea, orthopnoea, elevated jugular venous pressure, pulmonary rales, or pulmonary oedema according to chest radiography. These clinical signs and symptoms represented a change from the normal clinical state of the patient and were accompanied by either failing cardiac output, as determined by peripheral hypoperfusion (in the absence of other causes such as sepsis or dehydration), or peripheral or pulmonary oedema requiring treatment with intravenous diuretics, inotropes, or vasodilators.
Interobserver variability
In the first 30 enrolled cases, LA expansion index was measured by two independent observers. Interobserver variability was calculated as the difference between the values obtained by two observers divided by the mean. For LA expansion index measurements, interobserver variability was 4.4 6 6.3%. by chi-square analysis of categorical variables. The independent prognostic value was determined by incremental multivariate models adjusted for covariates showing significant (P < 0.05) associations with events in univariate analysis. The area (AUC) under the receiver operating characteristic (ROC) curve was used to evaluate the sensitivity and specificity of predictors of renal function decline. Multivariate logistic regression with adjustment for potential confounders was used to estimate 5-year cumulative renal decline rate according to LA expansion index quartile.
Statistical analyses
Results
Basic characteristics
Of the 804 patients enrolled in this study, 10 were lost to follow up, 34 were lost to regular renal function assessments, 20 died during follow-up (sepsis 8, lung cancer 3, cerebral infarction 2, intracranial haemorrhage 2, colon cancer 1, endometrical cancer 1, myocardial infarction with HF 1, sudden death 1, and trauma 1), and seven had obstructive uropathy (four with cancer, three with stones). Finally, 733 participants were under final analysis. Fifty-seven participants had reached an endpoint by the median 5.2-year follow-up. Of these, 19 had rapid renal decline, and 38 had incidental renal function decline. Nine of 19 rapid renal declines were associated with HF hospitalization. The average eGFR decreased from 77.9 6 18.7 to 53.2 6 22.8 mL/min/1.73 m 2 . The average annual reduction in eGFR was 7.6 6 10.7 mL/min/1.73 m 2 in the rapid renal decline group and 2.6 6 1.8 mL/min/1.73 m 2 in the incidental renal decline group. Univariate and multivariate analyses of predictors of renal function decline Table 2 shows the results of univariate and multivariate analyses of predictors of renal function decline. In univariate analysis, significant independent predictors of renal function decline included hypertension, AF and HF during follow-up, LV ejection fraction, pulmonary artery systolic pressure, diastolic dysfunction, LV mass index, Vol max , E/e 0 , and LA expansion index. In multivariate analysis, there were significant independent predictors of renal function decline included HF during follow-up, LV mass index, and LA expansion index. In multicollinearity analysis of renal function decline among LA expansion index, HF and AF during follow-up, the variance inflation factor was 1.024 for LA expansion index, 1.119 for HF during follow-up, and 1.109 for AF during follow-up. For predicting renal function decline, LA expansion index had a hazard ratio of 1.426 per 10% decrease, which indicated the high prognostic power of this index (95% confidence interval 1.276-1.671, P < 0.0001). Figure 1 shows that, in ROC curve analysis, an LA expansion index <78% was the best cut-off point for predicting renal function decline (AUC 0.804, sensitivity 81%, and specificity 77%).
Renal decline rate according to quartile of LA expansion index Figure 2 shows the 5-year cumulative rates of renal function decline, including both rapid and incidental renal function decline, according to LA expansion index quartile. In both the incidental and rapid renal decline groups, the reduction in LA expansion index had a strong relationship with the cumulative rate of renal function decline. Compared with patients who had LA expansion indices in the highest quartile, those with indices in the lowest quartile had a significantly higher probability of future degradation in renal function. Table 3 shows the unadjusted and adjusted rates of decline in renal function by quartile of LA expansion index. Compared with patients in the highest quartile, patients in the lowest quartile had a 9.7-fold higher unadjusted hazard ratio for decline in renal function. Even after adjusting for LV mass index and HF during follow-up, patients in the lowest quartile still had a significantly higher hazard ratio for decline in renal function (6.9-fold higher; P ¼ 0.002).
Longitudinal change in LA expansion index
A low LA expansion index at enrolment (cross-sectional data) was significantly associated with decline in renal function in this study cohort (122 6 73 vs. 79 6 32; P < 0.0001). Figure 3 shows the longitudinal change in LA expansion index according to presence or absence of decline in renal function. At end of the study, LA expansion index was available in 478 (70.7%) of 676 patients in the group without renal decline and was available in 47 (82.5%) of the 57 patients in the group with renal decline. In patients without renal decline, the 5-year change in LA expansion index was not statistically significant (122 6 73 at enrolment vs. 115 6 67 at 5 years; P ¼ 0.232). In contrast, the 5-year change in LA expansion index was statistically significant in patients with renal function decline (79 6 32 at enrolment vs. 52 6 24 at 5 years; P < 0.0001).
Discussion
Natriuretic peptide is reportedly associated with degraded renal function, which can then lead to end-stage renal disease. 5, 6, 27, 28 This association suggests that cardiovascular problems can lead to a loss of renal function. However, studies of this association have not used interim measures of kidney function and have only focused on cohorts who already had chronic renal dysfunction or HF. The current study, however, only enrolled patients with no history of diabetes or clinical HF before a clinical diagnosis of chronic kidney disease. Therefore, the cardiorenal interaction could be analysed at a much earlier stage, which provides the possibility that physicians can detect and intervene in patients at risk of renal function decline. LA expansion index is now a well-validated indicator of diastolic function and left ventricular filling pressure and is a prognostic indicator of adverse cardiovascular events. This cross-sectional cohort study showed that a poor LA expansion index is a significant prognostic indicator of decline in renal function. Although other diastolic parameters, including LA volume and E/e', were significantly associated with renal function decline in univariate analysis ( ( Figure 1) . Compared with patients with LA expansion indices in the highest quartile, those with indices in the lowest quartile had a sixfold higher relative risk of further renal decline, even after multivariate adjustment. Because dialysis for patients with renal failure is a potentially huge socio-economic burden, early identification of patients at high risk for renal degradation enables the possibility of changing adverse outcome or slowing its progression. Myocardial dysfunction significantly affects the progression of renal decline. Heart disease and kidney disease have complex relationships. 29 Reported mechanisms of cardiorenal interaction include altered haemodynamics, 30 activities of the sympathetic nervous system and the renin-angiotensin-aldosterone system, inflammation, oxidative stress, and atherosclerosis. 31, 32 These activities are associated with changes in vascular structure, including endothelial dysfunction, fibroelastic intimal thickening, increased extracellular matrix deposition, and vascular calcification, all of which can eventually cause arterial stiffness. Arterial stiffness is the main pathogenic mechanism of LV hypertrophy, diastolic HF, and isolated systolic hypertension. 33, 34 Arterial stiffness also increases blood flow and pressure pulsatility. At the renal microcirculation level, arterial stiffness induces kidney injury because low input impedance of the renal microvasculature makes kidneys particularly vulnerable to excessive transmission of pulsatile energy. 35 For example, recent prospective studies have revealed a negative relationship between arterial stiffness and annual decline in eGFR. 36 Arterial stiffness is also an independent predictor of all-cause and cardiovascular mortality in hypertensive patients and is associated with LV structural changes and diastolic function. [37] [38] [39] [40] Abhayaratna et al. 37 reported that 1 SD in the change in arterial stiffness (assessed by brachial/aortic pulse pressure, carotid-femoral pulse-wave velocity, or augmentation pressure) is associated with at least an 80% increase in the risk of diastolic dysfunction. It also showed that arterial stiffness correlates positively with LA volume and with diastolic dysfunction grade. Because LA expansion index has a strong logarithmical relationship with LV filling pressure, LA expansion index is sensitive to subtle changes in diastolic dysfunction and slight elevations in filling pressure.
This study shows that LA expansion index is highly sensitive, and that it may change before clinical diastolic dysfunction and renal decline become evident. Figure 3 shows that contributing factors affecting the progressive decline in renal function also worsen LA expansion index before renal function degrades. As it is persistent and ongoing, LA expansion index and renal function were decreased in the affected cohort but relatively stable in the unaffected cohort. Fifty-seven participants had reached the endpoints by the median 5.2-year follow-up- Figure 2 further shows that the baseline value for the index predicts further rapid or incidental declines in renal function. In contrast with Bansal et al. 6 who reported that high NT-ProBNP and high troponin T have a stronger association with rapid renal decline than with incidental renal decline, our results indicate that LA expansion index is significantly associated with both rapid and incidental renal declines. In the study, nine patients (47%; 9/19) with rapid renal decline were associated with HF hospitalization and three patients with acute renal failure, which required haemodialysis, were due to HF. According to our prior report, LA expansion index also correlates significantly to further HF hospitalization event.
14 For patients with low LA expansion index, it indicates vulnerability of renal function decline after repetitive HF. The results of this study have important clinical implications. In the non-diabetic, non-HF patients analysed in this study, those with a high LA expansion index had a low probability of decline in renal function whereas those with a low LA expansion index require close monitoring of this index and renal function. Physicians treating patients with a low baseline LA expansion index or a decreasing trend in this index should pay close attention to their blood pressure and their sodium intake and should avoid prescribing medications that can cause renal injury, such as non-steroid anti-inflammation drugs and aminoglycoside. HF itself is also an independent prognostic indicator of renal function decline (Tables 1 and 2 ). Physicians should be careful to avoid inadequate renal perfusion by either low cardiac output or over-diuresis during HF events. This could help avoid HF-related acute renal failure.
Study limitations
Some limitations of this study are noted. First, this study analysed data collected at a single tertiary centre, which may have resulted in selection bias. Although the follow-up period was up to 5 years, the event rate was relatively low because the study population had a relatively low risk. Therefore, a more detailed study in a larger population is needed to provide precise data for arterial stiffness and the causal relationship between LA expansion index and renal function decline. Secondly, other echocardiographic measures of LA function, including segmental atrial function, strain, strain rate, and atrial response to exercise, were not examined, so the predictive power could not be compared between LA expansion index, strain rate/ strain, and speckle tacking. 41 Thirdly, the MDRD formula is based on a calibrated serum creatinine method, which could possibly underestimate eGFR in mild renal insufficiency, potentially misclassifying patients as having a low GFR. 42 Fourthly, the applicability of these results in the general population is unknown because this analysis excluded patients with diabetes, HF, or chronic renal disease.
Conclusion
This prospective study of patients without diabetes, HF, or chronic renal disease showed that LA expansion index is useful for early identification of renal function degradation in the future and enables the possibility of changing this adverse outcome.
